NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for PHRMA · Pharmaceutical

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Medicare/Medicaid

Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry, Medicare Part B

Health Issues

Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.